Risk of Metformin in Patients With Type 2 Diabetes With COVID‐19: A Preliminary Retrospective Report-Reference-Cited by-同舟云学术

Risk of Metformin in Patients With Type 2 Diabetes With COVID‐19: A Preliminary Retrospective Report

Author:

Gao Yongchao¹²³⁴,Liu Tao⁵,Zhong Weijun¹²³⁴,Liu Rong¹²³⁴,Zhou Honghao¹²³⁴,Huang Weihua¹²³⁴,Zhang Wei¹²³⁴

Affiliation:

1. Department of Clinical Pharmacology Xiangya Hospital Central South University Changsha China

2. Institute of Clinical Pharmacology Hunan Key Laboratory of Pharmacogenetics Central South University Changsha China

3. Engineering Research Center of Applied Technology of Pharmacogenomics Ministry of Education Changsha China

4. National Clinical Research Center for Geriatric Disorders Changsha China

5. Shenzhen Center for Chronic Disease Control Shenzhen China

Funder

National Natural Science Foundation of China

Central South University

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

Reference20 articles.

4. World Health Organization (WHO).Coronavirus disease 2019 (COVID19): situation report—117. (WHO Geneva) (2020). Accessed May 16 2020.

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献